VIEMED HEALTHCARE, INC. Cash Flow Statement
VMD|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
VIEMED HEALTHCARE, INC. generated $45M in operating cash flow and $19M in free cash flow in FY2025. Free cash flow margin was 10.4% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | $10.2M | $6.2M | $6.2M | $9.1M | $31.5M | $8.5M | $9.5M |
| Depreciation & Amortization | $21.9M | $15.6M | $15.6M | $11.3M | $9.6M | $6.4M | $3.8M |
| Operating Cash Flow | $45.2M | $27.7M | $27.7M | $22.5M | $35.1M | $19.1M | $22.4M |
| Capital Expenditures | $26.1M | $22.9M | $22.9M | $19.7M | $13.0M | $13.4M | $6.1M |
| Free Cash Flow | $19.1M | $4.8M | $4.8M | $2.8M | $22.1M | $5.7M | $16.3M |
| Share Buybacks | $0 | $9.6M | $9.6M | $0 | $0 | $1.5M | $1.6M |
| FCF Margin | 10.4% | 3.5% | 3.5% | 2.4% | 16.8% | 7.1% | 25.2% |